Oh. I forgot. We need to add in the cost of the experimental drug. Found this:
It is a valid dilemma for the company. In its year end financial report for 2013, Chimerix reported a net loss for the year of $36.4 million, almost nine times the loss it reported in 2012. Providing Brincidofovir for compassionate use will cost the company about $50,000 per dose. Since the drug is not yet approved, most insurance will not cover it.
Citing Expense Drug Company Denies Potentially Life Saving Drug to Seven Year Old Boy
FUBAR